IGF-1 LR3 is a long-acting analog of insulin-like growth factor 1, engineered with an amino acid substitution and an N-terminal extension that reduce its binding affinity to IGF-binding proteins and extend its circulating half-life relative to native IGF-1 in laboratory models. It is not a naturally occurring human peptide — it is a lab-engineered research variant, which raises the sourcing bar rather than lowering it. A vial labeled "IGF-1 LR3" tells a lab nothing about whether the correct sequence, folding, and purity were actually achieved during synthesis; only independent analytical documentation does that.
What to verify before ordering
- Purity ≥98% by HPLC — reported with the chromatography method and column conditions disclosed, not a bare percentage on a label. Background: HPLC purity analysis.
- Mass spectrometry identity confirmation — IGF-1 LR3 is a larger, more structurally complex molecule than most short research peptides (it is a 83-residue protein analog, not a short chain), so sequence and mass confirmation matter even more than with simpler peptides. HPLC retention time alone cannot distinguish a correctly folded, full-length analog from a truncated or misfolded synthesis byproduct. See HPLC vs. mass spectrometry.
- Batch-specific Certificate of Analysis — tied to the lot actually shipped, not a template reused across runs. See how to read a COA.
- Correct lyophilized form and cold-chain handling — IGF-1 LR3's extended structure makes it more sensitive to degradation from improper storage or repeated freeze-thaw than smaller peptides. It should arrive lyophilized, not pre-mixed, with clear reconstitution guidance. See IGF-1 LR3 reconstitution and storage.
- Disclosed net peptide content — the gross vial weight (e.g., 1mg) includes counter-ions and residual moisture from lyophilization; actual peptide mass is lower. Suppliers willing to publish net content alongside gross label weight are giving labs an honest basis for calculating concentrations.
Why sourcing discipline matters more for this analog
Because IGF-1 LR3 is synthesized rather than naturally derived, small errors in the synthesis or purification process are more consequential than with shorter, simpler peptides — an incomplete sequence or a disulfide-bond mismatch can still register as "IGF-1 LR3" on a basic purity check while being structurally and functionally different from the intended analog in downstream research. That is precisely why mass spectrometry confirmation and a batch-matched COA are not optional extras for this compound; they are the only way a lab can know the material matches the analog described in the literature it's citing.
Questions worth asking any supplier
- Is the COA generated per production batch, with a lot number that matches what's printed on the vial received?
- Was identity testing performed by mass spectrometry, and is that data available on request? See third-party testing explained.
- Does the supplier disclose synthesis method (solid-phase synthesis route, purification steps) when asked directly?
- Are storage and handling instructions specific to IGF-1 LR3's stability profile, or generic boilerplate copied across every product page?
- Is sale explicitly restricted to research use, with no dosing or administration guidance implying otherwise?
A supplier that can answer these without hedging, and that will produce a batch-specific COA on request, is operating the way a laboratory reagent supplier should. Vague answers or a refusal to provide lot-matched documentation are reasons to source elsewhere.
Price relative to documentation
IGF-1 LR3 is more expensive to synthesize correctly than most shorter research peptides because of its length and the additional purification steps needed to achieve high purity at that size. Pricing that undercuts the market significantly while still claiming ≥98% HPLC purity and mass-spec-confirmed identity is worth scrutinizing — at minimum, ask to see the actual batch COA before assuming the claim is accurate.
Where to buy documented IGF-1 LR3
V8 Peptides supplies IGF-1 LR3 as a lyophilized powder verified to ≥98% purity by HPLC with mass-spectrometry-confirmed identity, accompanied by a batch-specific Certificate of Analysis with every order, shipped domestically via USPS. The vial is available on the IGF-1 LR3 research vial product page. For background on the analog's structure and binding behavior, see the IGF-1 LR3 mechanism of action reference, and for general sourcing criteria that apply across any research peptide, see the supplier checklist.
Research Use Only. Supplied strictly for laboratory research and development — not for human or veterinary use, consumption, or any therapeutic or diagnostic purpose. This article is research education, not usage guidance.